BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 24386222)

  • 1. Characterization of negative feedback network motifs in the TGF-β signaling pathway.
    Nicklas D; Saiz L
    PLoS One; 2013; 8(12):e83531. PubMed ID: 24386222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current perspectives on inhibitory SMAD7 in health and disease.
    de Ceuninck van Capelle C; Spit M; Ten Dijke P
    Crit Rev Biochem Mol Biol; 2020 Dec; 55(6):691-715. PubMed ID: 33081543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computational modelling of Smad-mediated negative feedback and crosstalk in the TGF-β superfamily network.
    Nicklas D; Saiz L
    J R Soc Interface; 2013 Sep; 10(86):20130363. PubMed ID: 23804438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory Smad7: emerging roles in health and disease.
    Briones-Orta MA; Tecalco-Cruz AC; Sosa-Garrocho M; Caligaris C; Macías-Silva M
    Curr Mol Pharmacol; 2011 Jun; 4(2):141-53. PubMed ID: 21222648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NEDD4-2 (neural precursor cell expressed, developmentally down-regulated 4-2) negatively regulates TGF-beta (transforming growth factor-beta) signalling by inducing ubiquitin-mediated degradation of Smad2 and TGF-beta type I receptor.
    Kuratomi G; Komuro A; Goto K; Shinozaki M; Miyazawa K; Miyazono K; Imamura T
    Biochem J; 2005 Mar; 386(Pt 3):461-70. PubMed ID: 15496141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roles for the MH2 domain of Smad7 in the specific inhibition of transforming growth factor-beta superfamily signaling.
    Mochizuki T; Miyazaki H; Hara T; Furuya T; Imamura T; Watabe T; Miyazono K
    J Biol Chem; 2004 Jul; 279(30):31568-74. PubMed ID: 15148321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Editorial Special Issue TGF-beta/BMP Signaling Pathway.
    Fabregat I; Herrera B; Sánchez A
    Cells; 2020 Oct; 9(11):. PubMed ID: 33121103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of TGF-beta signaling by Smad7.
    Yan X; Liu Z; Chen Y
    Acta Biochim Biophys Sin (Shanghai); 2009 Apr; 41(4):263-72. PubMed ID: 19352540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SMAD7 antagonizes key TGFβ superfamily signaling in mouse granulosa cells in vitro.
    Gao Y; Wen H; Wang C; Li Q
    Reproduction; 2013 Jul; 146(1):1-11. PubMed ID: 23633623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smad7 regulates the adult neural stem/progenitor cell pool in a transforming growth factor beta- and bone morphogenetic protein-independent manner.
    Krampert M; Chirasani SR; Wachs FP; Aigner R; Bogdahn U; Yingling JM; Heldin CH; Aigner L; Heuchel R
    Mol Cell Biol; 2010 Jul; 30(14):3685-94. PubMed ID: 20479122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamics and feedback loops in the transforming growth factor β signaling pathway.
    Wegner K; Bachmann A; Schad JU; Lucarelli P; Sahle S; Nickel P; Meyer C; Klingmüller U; Dooley S; Kummer U
    Biophys Chem; 2012 Mar; 162():22-34. PubMed ID: 22284904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth differentiation factor-9 signaling is mediated by the type I receptor, activin receptor-like kinase 5.
    Mazerbourg S; Klein C; Roh J; Kaivo-Oja N; Mottershead DG; Korchynskyi O; Ritvos O; Hsueh AJ
    Mol Endocrinol; 2004 Mar; 18(3):653-65. PubMed ID: 14684852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD109-mediated degradation of TGF-β receptors and inhibition of TGF-β responses involve regulation of SMAD7 and Smurf2 localization and function.
    Bizet AA; Tran-Khanh N; Saksena A; Liu K; Buschmann MD; Philip A
    J Cell Biochem; 2012 Jan; 113(1):238-46. PubMed ID: 21898545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevating CLIC4 in Multiple Cell Types Reveals a TGF- Dependent Induction of a Dominant Negative Smad7 Splice Variant.
    Shukla A; Yang Y; Madanikia S; Ho Y; Li M; Sanchez V; Cataisson C; Huang J; Yuspa SH
    PLoS One; 2016; 11(8):e0161410. PubMed ID: 27536941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural basis for inhibitory effects of Smad7 on TGF-β family signaling.
    Murayama K; Kato-Murayama M; Itoh Y; Miyazono K; Miyazawa K; Shirouzu M
    J Struct Biol; 2020 Dec; 212(3):107661. PubMed ID: 33166654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Smad7 Protein Interacts with Receptor-regulated Smads (R-Smads) to Inhibit Transforming Growth Factor-β (TGF-β)/Smad Signaling.
    Yan X; Liao H; Cheng M; Shi X; Lin X; Feng XH; Chen YG
    J Biol Chem; 2016 Jan; 291(1):382-92. PubMed ID: 26555259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphorylation of Smad7 at Ser-249 does not interfere with its inhibitory role in transforming growth factor-beta-dependent signaling but affects Smad7-dependent transcriptional activation.
    Pulaski L; Landström M; Heldin CH; Souchelnytskyi S
    J Biol Chem; 2001 Apr; 276(17):14344-9. PubMed ID: 11278814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smad7: not only a regulator, but also a cross-talk mediator of TGF-β signalling.
    Yan X; Chen YG
    Biochem J; 2011 Feb; 434(1):1-10. PubMed ID: 21269274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transforming Growth Factor-β Family Ligands Can Function as Antagonists by Competing for Type II Receptor Binding.
    Aykul S; Martinez-Hackert E
    J Biol Chem; 2016 May; 291(20):10792-804. PubMed ID: 26961869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Divergence and convergence of TGF-beta/BMP signaling.
    Miyazono K; Kusanagi K; Inoue H
    J Cell Physiol; 2001 Jun; 187(3):265-76. PubMed ID: 11319750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.